Weide Zhong

6.6k citations
217 papers · 4.7k indexed · h-index 40

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Cancer, Hypoxia, and Metabolism
    • RNA modifications and cancer
    • Circular RNAs in diseases
    • Signaling Pathways in Disease

Papers in

    • Cancer, Lipids, and Metabolism 23
    • Cancer, Hypoxia, and Metabolism 22
    • Cancer-related molecular mechanisms research 17
    • MicroRNA in disease regulation 15
    • Prostate Cancer Treatment and Research 50

Weide Zhong

207 papers receiving 4.6k citations

Peers

Weide Zhong
Comparison fields: 5 of 133
  • Cancer Research 1.7k
  • Molecular Biology 2.8k
  • Pulmonary and Respiratory Medicine 1.1k
  • Oncology 879
  • Immunology 490
Replace Zhong Chen with:
Zhong Chen China
Yinghao Sun China
Alexander T.H. Wu Taiwan
Wei Guo China
Mohammad Obaidul Hoque United States
Eiso Hiyama Japan
Jesús M. Bañales Spain
Zamaneh Kassiri Canada
Yasuhiro Miki Japan
Carsten Willam Germany
Weide Zhong relative to Zhong Chen China Zhong Chen's profile →
Citations per field
00.5×1.5×2.5×
Zhong Chen · 1×
Citations per year

Countries citing papers authored by Weide Zhong

Since Specialization
Citations

This map shows the geographic impact of Weide Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weide Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weide Zhong more than expected).

Fields of papers citing papers by Weide Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weide Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weide Zhong. The network helps show where Weide Zhong may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Weide Zhong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Weide Zhong Line = papers co-authored together Weide Zhong links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20247
3 20241
4 20249
5 20241
6 202411
7 202312
8 202226
9 202213
10 202183
11 202051
12 202013
13 202011
14
Carbon Nanospheres Exert Antitumor Effects Associated with Downregulation of 4E-BP1 Expression on Prostate Cancer
20201
15
Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer
20203
16 201888
17 2018153
18 201832
19 2015103
20 200857

About Weide Zhong

Weide Zhong is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Immunology and Allergy, having authored 217 papers that have together received 4.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (50 papers), Cancer, Lipids, and Metabolism (23 papers), Cancer, Hypoxia, and Metabolism (22 papers), Cancer-related gene regulation (18 papers), Epigenetics and DNA Methylation (18 papers), Cancer-related molecular mechanisms research (17 papers), MicroRNA in disease regulation (15 papers) and Signaling Pathways in Disease (14 papers). The work is most often cited by research in Cancer Research (1.7k citations), Molecular Biology (2.8k citations), Pulmonary and Respiratory Medicine (1.1k citations), Oncology (879 citations) and Immunology (490 citations). Weide Zhong has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Zhaodong Han, Huichan He, Funeng Jiang, Qi-Shan Dai, Yuxiang Liang, Jianguo Zhu, Xue‐cheng Bi, Chin‐Lee Wu, Chao Cai and Yangjia Zhuo. Their work appears in journals such as Medical Oncology, Clinical and investigative medicine, Frontiers in Oncology, Cancer Letters and Pathology & Oncology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026